1. USP 18–NF 13,1970
2. USP 42–NF 37,2018
3. USP 42–NF 37, Validation of Compendial Procedures <1225>,2018
4. Waiver of in Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System: Guidance for Industry,2018
5. USP 42–NF 37, Dissolution <711> Rockville,2018